Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Emily Leven MD

Emily A. Leven MD

Chief Resident, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York

Dr. Leven is board-certified in internal medicine and is completing chief residency at Mount Sinai Hospital, where she will go on to complete gastroenterology fellowship training. Her clinical interests lie in immune-mediated gastrointestinal and liver diseases, as well as quality improvement. Her recent scholarly work examines outcomes in liver transplantation among older adults, liver-related risk stratification in end-stage heart disease, primary immunodeficiencies, and serum antibody responses to COVID-19. Her quality improvement work has focused on medication adherence and safety of inter-hospital transfers. The products of this work have been published in Lancet Microbe, Clinical Transplantation, Journal of Clinical Immunology, and BMJ Open Quality, among others. She was accepted to the American Association for the Study of Liver Diseases Emerging Liver Scholars Program in 2019.

Disclosures

Dr. Leven has no relevant disclosures.

Recent Contributions to PracticeUpdate:

  1. Survival of Patients With Alcohol-Associated Hepatitis Denied Liver Transplant

Most Read This Week

Recently Updated